UC HEALTH LINE: Radiofrequency Ablation Can Ease Breathing Difficulties
CINCINNATIIf youre experiencing chronic breathing difficulties, a simple procedure with a complicated name could be the answer to your problem.
Radiofrequency ablation of the turbinatesput more simply, reducing the size of tissue within the nose with the aid of a needle-equipped heating deviceis a procedure that can be done in a physicians office under local anesthesia.
That gives it a big advantage over traditional surgery, which involves removing part of the turbinates under general anesthesia in an operating room, says Lee Zimmer, MD, an assistant professor in the University of Cincinnati (UC) Department of OtolaryngologyHead and Neck Surgery.
Its quicker, safer, convenient and painless, says Zimmer, adding that the procedure itself only takes about 12 minutes after the local anesthetic takes effect.
Turbinates are structures located inside the nosethree on each sidecovered with mucus membranes. They warm and moisten air that is breathed in and also trap allergens, bacteria and viruses, keeping them from gaining access to the body.
Enlarged turbinates hinder air intake, so the goal of radiofrequency ablation is to shrink them so the patient gains more volume for breathing.
Every time you increase the radius of space in the nose youre increasing airflow to the power of 4, Zimmer says. So you dont need a lot.
Inserting a needle into three points on each of the two inferior (lowest) turbinates, Zimmer heats the tissue to approximately 70 degrees Celsius (158 degrees Fahrenheit). That breaks down protein, shrinking the size of the turbinate, and causes an inflammatory reactionscarringwhich also serves to shrink the turbinate.
During the first few days of recovery, Zimmer recommends saltwater sprays and a decongestant spray for two or three days, plus over-the-counter Tylenol as needed for discomfort. It takes about four weeks to get 80 percent healing from the scarring, Zimmer says, and the typical patient feels a difference in breathing by that time.
Likely candidates for the procedure are patients who complain of nasal congestionnot sinusitis (inflammation of the sinuses)who have been treated with prescription medications without success. Because of the electrical current involved, the procedure is not performed on patients who use pacemakers.
Tags
Related Stories
UC expert weighs in on current MASH treatment approaches
June 5, 2026
As MedCentral recently reported, pending broader pharmacologic approvals for metabolic dysfunction-associated steatohepatitis (MASH), lifestyle modifications remain the go-to intervention.
At least two weather patterns increase headaches, UC study suggests
June 4, 2026
University of Cincinnati physicians and collaborators identified two specific weather patterns that increase headache and migraine risk and found the preventive medication fremanezumab (Ajovy) can reduce weather‑associated headaches. The findings will be presented at the American Headache Society Annual Scientific Meeting in Orlando.
UC researcher secures $3.3M grant to study microplastics’ impact on heart
June 2, 2026
The National Institute of Environmental Health Sciences awarded a $3.3M grant to University of Cincinnati researcher Hong‑Sheng Wang, PhD, to study how microplastics and nanoplastics affect cardiovascular health.